http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107115273-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
filingDate 2016-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2020-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-107115273-B
titleOfInvention Levo-oxiracetam injection with good stability and preparation method thereof
abstract The levo-oxiracetam injection with good stability is characterized by being prepared from the following raw and auxiliary materials in percentage by weight: 52% -65% of levo-oxiracetam, 13% -27% of glycerol, 12% -25% of glycine and 1% -5% of benzyl alcohol; the solution pH of the levo-oxiracetam injection prepared according to the invention is basically unchanged in the sterilization process, the finished product has good stability and long validity period which can reach more than 18 months, the product has few impurities in the validity period, the total impurities are less than 0.38 percent, the main drug solubility of the product is good, the insoluble particles are less than 25 mu m, the pain of patients in the injection process is reduced, and the compliance of the patients is good.
priorityDate 2016-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4626
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23677676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18461115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447917097
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414031055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453918403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450648135
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672064
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21696466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447574277

Total number of triples: 40.